| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZIC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-08 |
| mRNA | NCAPH | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | TRA2B | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | ME2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | RNPS1 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | SRSF7 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | NONO | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | PPP1R8 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
